Literature DB >> 1857346

Free radicals involvement in neurological porphyrias and lead poisoning.

H P Monteiro1, E J Bechara, D S Abdalla.   

Abstract

Porphyrias are inherited and acquired diseases of erythroid or hepatic origin, in which there are defects in specific enzymes of the heme biosynthetic pathway. In patients with intermittent acute porphyria and lead poisoning the erythrocytic activities of superoxide dismutase and glutathione peroxidase are reported to be increased. Our studies demonstrated that d-aminolevulinic acid, a heme precursor accumulated in both diseases, undergoes enolization at pH less than 7.0 before it autoxidizes. The autoxidation of d-aminolevulinic acid, in the presence or absence of oxyhemoglobin has been proposed as a source of oxy and carbon-centred radicals in the cells of intermittent acute porphyria and saturnism carriers. Thus, the increased levels of antioxidant enzymes can be viewed as an intracellular response against the deleterious effects of these extremely reactive species.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1857346     DOI: 10.1007/bf00229595

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  78 in total

Review 1.  Porphyrins and related compounds as photodynamic sensitizers.

Authors:  J D Spikes
Journal:  Ann N Y Acad Sci       Date:  1975-04-15       Impact factor: 5.691

2.  Study of factors causing excess protoporphyrin accumulation in cultured skin fibroblasts from patients with protoporphyria.

Authors:  J R Bloomer; D A Brenner; M J Mahoney
Journal:  J Clin Invest       Date:  1977-12       Impact factor: 14.808

3.  The inhibition of red cell and brain ATPase by delta-aminolaevulinic acid.

Authors:  D Becker; D Viljoen; S Kramer
Journal:  Biochim Biophys Acta       Date:  1971-01-05

Review 4.  The importance of free radicals and catalytic metal ions in human diseases.

Authors:  B Halliwell; J M Gutteridge
Journal:  Mol Aspects Med       Date:  1985

Review 5.  Neurologic manifestations of acute porphyria.

Authors:  H L Bonkowsky; W Schady
Journal:  Semin Liver Dis       Date:  1982-05       Impact factor: 6.115

6.  Effect of lead ions on chick-embryo liver mitochondrial delta-aminolaevulinate synthase.

Authors:  B A Pirola; I A Borthwick; G Srivastava; B K May; W H Elliott
Journal:  Biochem J       Date:  1984-09-15       Impact factor: 3.857

7.  Regulation of catalase synthesis in Salmonella typhimurium.

Authors:  G J Finn; S Condon
Journal:  J Bacteriol       Date:  1975-08       Impact factor: 3.490

8.  Induction of superoxide dismutase by molecular oxygen.

Authors:  E M Gregory; I Fridovich
Journal:  J Bacteriol       Date:  1973-05       Impact factor: 3.490

9.  New type of acute porphyria with porphobilinogen synthase (delta-aminolevulinic acid dehydratase) defect in the homozygous state.

Authors:  M Doss; J Schneider; R Von Tiepermann; A Brandt
Journal:  Clin Biochem       Date:  1982-02       Impact factor: 3.281

10.  Production of superoxide anion during the oxidation of hemoglobin by menadione.

Authors:  B Goldberg; A Stern
Journal:  Biochim Biophys Acta       Date:  1976-07-21
View more
  14 in total

Review 1.  Diagnosis and management of porphyria.

Authors:  H Thadani; A Deacon; T Peters
Journal:  BMJ       Date:  2000-06-17

2.  Neuropsychiatric porphyria in patients with refractory epilepsy: report of three cases.

Authors:  A S Winkler; T J Peters; R D C Elwes
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-03       Impact factor: 10.154

3.  Psychiatric Manifestations in three cases of Acute Intermittent Porphyria.

Authors:  Neatu Narang; A Banerjee; J Kotwal; Jasmeet Kaur; Y V Sharma; C S Sharma
Journal:  Med J Armed Forces India       Date:  2011-07-21

4.  Systemic inflammation in acute intermittent porphyria: a case-control study.

Authors:  E Storjord; J A Dahl; A Landsem; H Fure; J K Ludviksen; S Goldbeck-Wood; B O Karlsen; K S Berg; T E Mollnes; E W Nielsen; O-L Brekke
Journal:  Clin Exp Immunol       Date:  2016-12-15       Impact factor: 4.330

5.  Motor neuropathy in porphobilinogen deaminase-deficient mice imitates the peripheral neuropathy of human acute porphyria.

Authors:  R L Lindberg; R Martini; M Baumgartner; B Erne; J Borg; J Zielasek; K Ricker; A Steck; K V Toyka; U A Meyer
Journal:  J Clin Invest       Date:  1999-04       Impact factor: 14.808

6.  Melatonin prevents delta-aminolevulinic acid-induced oxidative DNA damage in the presence of Fe2+.

Authors:  W Qi; R J Reiter; D X Tan; L C Manchester; J R Calvo
Journal:  Mol Cell Biochem       Date:  2001-02       Impact factor: 3.396

7.  delta-Aminolevulinic acid effects on neuronal and glial tumor cell lines.

Authors:  L Helson; S Braverman; J Mangiardi
Journal:  Neurochem Res       Date:  1993-12       Impact factor: 3.996

Review 8.  Porphyric Neuropathy: Pathophysiology, Diagnosis, and Updated Management.

Authors:  Mohamed Kazamel; Robert J Desnick; John G Quigley
Journal:  Curr Neurol Neurosci Rep       Date:  2020-10-07       Impact factor: 5.081

Review 9.  Challenges associated with metal chelation therapy in Alzheimer's disease.

Authors:  Muralidhar L Hegde; P Bharathi; Anitha Suram; Chitra Venugopal; Ramya Jagannathan; Pankaj Poddar; Pullabhatla Srinivas; Kumar Sambamurti; Kosagisharaf Jagannatha Rao; Janez Scancar; Luigi Messori; Luigi Zecca; Paolo Zatta
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

10.  Oxidative stress and antioxidant defense.

Authors:  Esra Birben; Umit Murat Sahiner; Cansin Sackesen; Serpil Erzurum; Omer Kalayci
Journal:  World Allergy Organ J       Date:  2012-01-13       Impact factor: 4.084

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.